Hypertension
Conditions
Keywords
Hypertension, potassium salts
Brief summary
The purpose of this study is to determine the effect of potassium chloride and potassium bicarbonate on blood pressure and also to determine whether increasing potassium intake has beneficial effects on the surrogate markers of target organ damage in cardiovascular disease, as well as on bone health.
Detailed description
Randomised trials have shown that increasing potassium intake lowers blood pressure. However, most previous trials used potassium chloride. Whereas, potassium in fruits and vegetables is not a chloride salt, but a mixture of potassium phosphate, sulphate, citrate, and many organic anions, most of which are precursors of potassium bicarbonate. It is unclear whether non-chloride salt of potassium has greater or lesser effect on blood pressure compared to potassium chloride. Experimental studies in animals and epidemiological studies in humans suggest that a high potassium intake may have beneficial effects on the cardiovascular system and the kidney, independent of its effect on blood pressure, and also reduce the risk of osteoporosis. We propose to carry out a randomised double-blind trial to compare potassium bicarbonate with potassium chloride looking at their effect on blood pressure, and also to determine whether these potassium salts have beneficial effects on the cardiovascular system, kidney and bone health. Comparisons: potassium chloride vs potassium bicarbonate vs placebo.
Interventions
BEHAVIORALPotassium supplementation
Sponsors
St George's, University of London
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Patients with untreated essential hypertension (sitting systolic blood pressure between 140 and 170 mmHg and/or sitting diastolic blood pressure between 90 and 105 mmHg); * Age 18 - 75 years.
Exclusion criteria
* Individuals younger than 18 or older than 75 years; * Individuals with impaired renal function with plasma creatinine greater than 120 umol/L for non-blacks or 150 umol/L for blacks; * Individuals with chronic diarrhea, or history of peptic ulcer; * Individuals with baseline plasma potassium values greater than 5.0 mmol/L; * Individuals with severe hypertension i.e. blood pressure \> 170/105 mmHg; * Individuals with diabetes mellitus; * Individuals with any secondary cause of hypertension; * Individuals with malignancy or liver disease; * Individuals with ischaemic heart disease or heart failure; * Females who are pregnant or breast feeding or on the oral contraceptive pill.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure and markers of target organ damage and bone health at 4 weeks of potassium supplementation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparisons among different treatments in blood pressure and markers of target organ damage and bone health. | — |
Countries
United Kingdom
Contacts
Primary ContactFeng J He, PhD
Backup ContactGraham A MacGregor, MD
Outcome results
None listed